orexin-2 receptor antagonists (Ligand/Neurocrine)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameorexin-2 receptor antagonists (Ligand/Neurocrine)
Drug Alias Nameorexin-2 receptor antagonists (Pharmacopeia/Neurocrine)OX2-R antagonists (Pharmacopeia/Neurocrine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 antagonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacopeia Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacopeia LlcLigand Pharmaceuticals IncNeurocrine Biosciences Inc
Active IndicationsN/A
Inactive IndicationsSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A